Table 1.
Side effects in cynomolgus monkeys treated with DT388IL3 intravenously for up to six every other day doses
Dose (μg/kg every other day IV×6) | |||||
---|---|---|---|---|---|
100 | 100 | 150 | 150 | Control | |
Toxicity | 7228 | 7229 | 7225a | 7226b | 7227 |
Hematology | |||||
Leukopenia | 0 | 0 | 0 | 0 | 0 |
Leukocytosis | 1 | 0 | 3 | 2 | 1 |
Thrombocytopenia | 0 | 0 | 1 | 2 | 0 |
Anemia | 2 | 3 | 2 | 3 | 2 |
Gastrointestinal/appetite | |||||
Anorexia | 1 | 1 | 3 | 3 | 0 |
Weight loss | 0 | 0 | 1 | 0 | 0 |
Diarrhea | 0 | 0 | 1 | 1 | 0 |
Liver | |||||
Alanine transferase elevation | 0 | 1 | 2 | 2 | 0 |
Hypoalbuminemia | 2 | 2 | 3 | 2 | 0 |
Renal/metabolic | |||||
Elevated blood urea nitrogen | 0 | 0 | 0 | 0 | 0 |
Elevated creatinine | 0 | 0 | 0 | 0 | 0 |
Hypokalemia | 0 | 0 | 1 | 1 | 0 |
Overall health | |||||
Activity level | 0 | 0 | 3 | 2 | 0 |
Discomfort/malaise | 1 | 1 | 3 | 3 | 0 |
Uckun toxicity grading system with grades 0–3 (0 within normal limits, 1 mild, 2 moderate, 3 severe)
aThrough three doses
bThrough five doses